FDA Commissioner Gottlieb: Establishment Pick, Strong Policy Background

Cole Werble and Ramsey Baghdad discuss their initial impressions of Scott Gottlieb as President Trump's choice to lead FDA, his unique policy experience, what it means from the drug industry, "Council of Elders" drug approvals, and how it impacts the user fee negotiations.